Donate to TB Vets Now!

Please check all information including the amount before submission. Should you encounter other errors, please clear your browser's cookies/cache and refresh the page. To avoid time-outs, please fill out the form in less than ten minutes. You may also donate through our stand-alone page at tbvets.org/donate. Thank you for your support.
  • About Us
    • Respiratory Equipment
    • Research
    • Education
  • Financial Information
  • Annual Report
  • How to Help
    • Sponsorship
    • Gift in a Will
    • Monthly Giving
    • Tax Savings
    • Tribute Giving
  • News + Stories
  • Respiratory Grants
  • Key Tag Program
  • Fitness Program
  • Webinars
  • Contact Us
  • Share your memory of a Veteran
Menu
Donate
Donate

TB & COVID-19: Battling Respiratory Diseases with World-Renowned Research

The generosity of TB Vets donors like you has helped achieve significant progress in Tuberculosis (TB) Research at Vancouver General Hospital / University of British Columbia (VGH/UBC). Additionally, your support has helped mobilize resources during the COVID-19 crisis and initiate research into SARS CoV-2 drug discovery.
Led by Dr. Yossef Av-Gay, the TB Research Program at VGH/UBC focuses on finding new TB drugs. One of the approaches used in the research is to identify key human genes and processes which enables the immune cells of a person (the human host) to fight Mycobacterium tuberculosis. This is called Host Directed Therapy and is currently on the forefront of infectious diseases research. 
 
The team has screened millions of compounds using systems (see photos) and found multiple drug candidates called lead compounds. These compounds target human proteins and activate them in the infected cells such that they are able to clear the infection. 
 
The team has published their findings in scientific journals and is currently gearing up their drug development program.
 

The research team of  Dr. Yossef Av-Gay at VGH/UBC

TB Research in the time of COVID-19

When COVID-19 struck, Dr. Av-Gay’s team was forced to temporarily halt their research. The highly secure lab was then adapted for work with the high-risk coronavirus. 
 
Moreover, their TB drug discovery technology was adapted for use. A series of compounds have been identified that are able to kill SARS CoV-2 inside human cells with high efficiency. Currently, these compounds are being analyzed for their therapeutic effect in human cells and lung organoids.
 
In August 2020, the research team resumed work on TB together with the new COVID-19 drug development program.
 

When COVID-19 struck, the TB Research facility at VGH was adapted for work with the high-risk coronavirus.

Amidst respiratory crises of all kinds, the ongoing support of TB Vets donors like you truly makes a difference. Your loyal support helps BC’s respiratory frontline with important scientific research and resources that can save lives globally.*

Donate toward meaningful respiratory research today
Back to Impact Stories
PrevPrevious Impact StoryWhistler Receives TB Vets-Funded Ventilator, A Need Even Before the Pandemic
Next Impact StoryDelta Hospital’s ER is Equipment-Ready, Thanks to TB Vets DonorsNext

Find us on social media

Facebook-f Instagram Linkedin

Subscribe to Updates

Supporting frontline medical heroes.

Subscribe now!
Donate Today
Contact us
healthcare-champion-2024-web

© 2023 TB Vets Charitable Foundation | Privacy Policy

Registered Charity #87416 1482 RR0001